Skip to main content
. 2020 Jul 26;12(1):99–108. doi: 10.1111/jdi.13324

Figure 3.

Figure 3

The summary of recommendations regarding antiplatelet strategies in type 2 diabetes patients for cardiovascular disease (CVD) prevention. ACS, acute coronary syndrome; ASA, acetylsalicylic acid; ASCVD, arteriosclerotic cardiovascular disease; CABG, coronary artery bypass grafting; CCS, chronic coronary syndrome; DAPT, dual antiplatelet therapy; PCI, percutaneous coronary intervention; T2DM, type 2 diabetes mellitus.